Navigation Links
InterMune to Divest Actimmune® (Interferon Gamma-1b)
Date:5/21/2012

scribing information regarding Actimmune, including the product's safety profile, by visiting www.actimmune.com.

About InterMune
InterMune is a biotechnology company focused on the research, development and commercialization of innovative therapies in pulmonology and orphan fibrotic diseases.  In pulmonology, we are focused on therapies for the treatment of idiopathic pulmonary fibrosis (IPF), a progressive and fatal lung disease.  Pirfenidone, the only medicine approved for IPF anywhere in the world, is approved for marketing by InterMune in the EU as Esbriet® and is currently in a Phase 3 clinical trial to support regulatory registration in the United States.  InterMune's research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases.  For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to our expectations of the uses of the capital from the divesture of Actimmune for investing in the registration and commercialization of Esbriet and the cash infusion to execute our Vision 2015 strategic plan.

Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause actual results to be materially different from any results expressed or implied by such forward-looking statements. For example, there are risks associated with the closing of the transaction for the divesture of Actimmune, including the ability o
'/>"/>

SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 ... Group") the regenerative medical devices company, announces that ... post-acute wound care market as Tissue Regenix Wound ... under Medicare administrator, First Coast Service Options Inc. ... , Puerto Rico ...
(Date:7/30/2015)... 30, 2015 ReportsnReports.com ... analyzing tumor biomarker tests, imaging, endoscopy and ... the global industry by technology and application. ... (Tumor Biomarker Tests, Imaging, Endoscopy and Biopsy) ... about 9 companies and supported with 180 ...
(Date:7/29/2015)... , July 30, 2015 ... Guidance   for ... Core Earnings and Core ... Highlights of Q1 results  ... Underlying core earnings and underlying core EPS were flat, year-to-year , ...
Breaking Medicine Technology:Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 2Tissue Regenix Group plc: First Coast Service Options Inc. Approves Medicare Coverage for DermaPure 3Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 2Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 3Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 4Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 5Cancer Diagnostics Market to see 12% CAGR to 2020: Analysis of Tumor Biomarker Tests, Imaging, Endoscopy, Biopsy and More in New Research Reports 6Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 2Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 3Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 4Takeda Reports 1st Quarter Results of FY2015 with Underlying Revenue Growth of +6.1% 5
... SHENZHEN, China , May 5 /PRNewswire-Asia/ ... Medical" or the "Company"), a leading manufacturer of,medical dressings, ... consumer products industries, today announced that it will,release financial ... on, Tuesday, May 11 , before the market open. ...
... SAN DIEGO , May 5 Sequenom, ... May 3, 2010 , following a hearing, the U.S. District ... an order approving the stipulation of settlement reached in the ... re Sequenom, Inc. Securities Litigation , Master File No. 3:09-cv-00921 LAB-WMC. ...
Cached Medicine Technology:Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 2Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 3Winner Medical Group Inc. to Host Second Quarter Fiscal Year 2010 Earnings Conference Call on Tuesday, May 11, 2010 at 5:00 p.m. EDT 4Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit 2
(Date:7/30/2015)... (PRWEB) , ... July 30, ... ... released a video, “Beachside Nursing Center,” to announce its position as one ... ratings. Beachside's administrator and staff members support the CMS rating system, which ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... Paul Zaichik Creates New Tool That Increases Training Capability , World ... new tool called Zejax ( http://www.Zejax.com ), that dramatically increases a person’s training ...
(Date:7/30/2015)... ... July 30, 2015 , ... Boston Web ... annual All-Stars Summit. Google Partners is the platform for search marketing agencies to ... support and tools necessary to run successful search marketing campaigns. Google Partners also ...
(Date:7/30/2015)... , ... July 30, 2015 , ... Gummy smile ... lip lowering, gum contouring and surgery, as well as the patented gum depigmentation treatmet. ... has made him popular with many patients from around the world. , “Like treatment ...
(Date:7/30/2015)... ... ... InventHelp, a leading inventor service company, announces that one of ... easy to apply lotion or medication to a hard-to-reach area. This invention is patented. ... medication to the back, and provides thorough coverage. The product would prevent the user ...
Breaking Medicine News(10 mins):Health News:Beachside Nursing Center Releases New Video 2Health News:Zejax is a Revolutionary New Way of BodyWeight Training Without Weights 2Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Gummy Smile Dentist, Alex Farnoosh DMD, is Now Offering Comprehensive Treatment Options for Gummy Smiles 2Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... SmartSponge(TM) System Alerts Surgical Staff If Sponges Remain ... Cardinal Health, a global,provider of products and services ... today announced an agreement with ClearCount Medical,Solutions to ... and Drug,Administration that integrates both counting and detection ...
... Inc. (OTC Bulletin Board: SPNG) Darryl Strawberry and ... involvement with,SpongeTech Delivery Systems, Inc. "As the outreach ... about my foundation,s involvement with SpongeTech.",SpongeTech,s Puddle Pals ... with,autism, and other special needs, helping them to ...
... Students for Community Mental Health Service, ... Pharmaceutical, Inc., ROCKVILLE, Md., April 1 ... as the recipients of Helping,Hands Grants. Each school ... health service project initiated and managed by medical ...
... focus entirely on ... medical technology industry, BATESVILLE, Ind. ... formerly known as Hillenbrand Industries, Inc.,today announced completion of the ... its funeral services operating,company Batesville Casket Company., Hill-Rom is ...
... TUSTIN, Calif., April 1, 2008 AMDL, ... California, with operations in,Shenzhen, Jiangxi, and Jilin, ... In combination with its subsidiary Jade,Pharmaceutical Inc. ... manufacture, and marketing of diagnostic, pharmaceutical,nutritional supplement, ...
... 1, 2008 Cod liver oil is a,valuable source ... naturally,occurring Vitamins A and D for our animal companions. ... the natural products industry,introduces two sizes of Pet Cod ... dogs and cats. Unlike many pet products, the company ...
Cached Medicine News:Health News:Cardinal Health, ClearCount Medical Solutions Sign Primary Distribution Agreement for RFID-Enabled Sponge Counting, Detection System 2Health News:Cardinal Health, ClearCount Medical Solutions Sign Primary Distribution Agreement for RFID-Enabled Sponge Counting, Detection System 3Health News:SpongeTech Delivery Systems, Inc. to Donate to The Darryl Strawberry Foundation!! 2Health News:American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 2Health News:American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 3Health News:American Psychiatric Foundation Announces Recipients of 2008 Helping Hands Grants 4Health News:Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies 2Health News:Hill-Rom Holdings, Inc. Announces Completion of Separation of Hillenbrand Industries Creating Two Public Companies 3Health News:AMDL Reports 2007 Financial Results and 2008 Operating Strategy 2Health News:AMDL Reports 2007 Financial Results and 2008 Operating Strategy 3Health News:Dogs and Cats Need Omega-3 Fatty Acids Just as Humans Do - Nordic Naturals Offers Premium Fish Oil to Supplement Pets' Diet! 2
... most total knee manufacturers focus attention on ... is instrumentation. The Profix Total Knee System ... total knee implant system and the tools ... Whiteside, M.D., widely recognized for innovation in ...
Cruciate retaining, posterior stabilized and constrained components....
Maximum contact. Minimum wear. Outstanding results....
...
Medicine Products: